DK1016669T3 - Nye erythromycinderivater, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler - Google Patents

Nye erythromycinderivater, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler

Info

Publication number
DK1016669T3
DK1016669T3 DK99402783T DK99402783T DK1016669T3 DK 1016669 T3 DK1016669 T3 DK 1016669T3 DK 99402783 T DK99402783 T DK 99402783T DK 99402783 T DK99402783 T DK 99402783T DK 1016669 T3 DK1016669 T3 DK 1016669T3
Authority
DK
Denmark
Prior art keywords
pharmaceuticals
processes
preparation
erythromycin derivatives
new erythromycin
Prior art date
Application number
DK99402783T
Other languages
Danish (da)
English (en)
Inventor
Constantin Agouridas
Alexis Denis
Claude Fromentin
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1016669T3 publication Critical patent/DK1016669T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK99402783T 1998-11-10 1999-11-09 Nye erythromycinderivater, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler DK1016669T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9814145A FR2785612A1 (fr) 1998-11-10 1998-11-10 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
DK1016669T3 true DK1016669T3 (da) 2003-05-26

Family

ID=9532584

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99402783T DK1016669T3 (da) 1998-11-10 1999-11-09 Nye erythromycinderivater, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler

Country Status (28)

Country Link
US (2) US6455505B2 (xx)
EP (1) EP1016669B1 (xx)
JP (1) JP4698783B2 (xx)
KR (1) KR100567695B1 (xx)
CN (2) CN1240708C (xx)
AR (1) AR025814A1 (xx)
AT (1) ATE232879T1 (xx)
AU (1) AU766138B2 (xx)
BR (1) BR9915236A (xx)
CA (1) CA2350651C (xx)
CZ (1) CZ20011622A3 (xx)
DE (1) DE69905447T2 (xx)
DK (1) DK1016669T3 (xx)
EA (1) EA200100533A1 (xx)
ES (1) ES2189365T3 (xx)
FR (1) FR2785612A1 (xx)
HR (1) HRP20010335B1 (xx)
HU (1) HUP0104035A3 (xx)
IL (2) IL142996A0 (xx)
NO (1) NO20012272L (xx)
NZ (1) NZ511609A (xx)
PL (1) PL348098A1 (xx)
PT (1) PT1016669E (xx)
SI (1) SI20640A (xx)
TR (1) TR200101286T2 (xx)
TW (1) TWI237027B (xx)
WO (1) WO2000027857A2 (xx)
ZA (1) ZA200103801B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3947360B2 (ja) * 1999-01-27 2007-07-18 ファイザー・プロダクツ・インク ケトリド抗生物質
IL145739A0 (en) 1999-05-24 2002-07-25 Pfizer Prod Inc 13-methyl-erythromycin derivatives
ATE271062T1 (de) 2000-06-30 2004-07-15 Pfizer Prod Inc Makrolid-antibiotika
JP2004017020A (ja) * 2002-06-20 2004-01-22 Sony Corp コーティング方法および被コーティング粒子
ES2552682T3 (es) 2003-03-10 2015-12-01 Merck Sharp & Dohme Corp. Agentes antibacterianos novedosos
US20080287376A1 (en) * 2004-07-28 2008-11-20 Mohammad Salman Ketolide Derivatives as Antibacterial Agents
WO2006046112A2 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
EP2214484A4 (en) * 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
CN105616437A (zh) * 2008-10-24 2016-06-01 森普拉制药公司 使用含三唑的大环内酯的生物防御
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
EP2475253B1 (en) 2009-09-10 2016-10-26 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and mac diseases
CA2793884C (en) 2010-03-22 2019-09-10 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
DK2571506T3 (en) 2010-05-20 2017-08-28 Cempra Pharmaceuticals Inc PROCEDURES FOR THE MANUFACTURE OF MACROLIDES AND KETOLIDES AND INTERMEDIATES
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
AU2013239696C1 (en) 2012-03-27 2018-11-29 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
EP2968801B1 (en) 2013-03-14 2018-09-26 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
US9751908B2 (en) 2013-03-15 2017-09-05 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
CA2908575C (en) 2013-04-04 2021-11-16 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
EP3211997A4 (en) 2014-10-08 2018-10-24 President and Fellows of Harvard College 14-membered ketolides and methods of their preparation and use
US10640528B2 (en) 2015-03-25 2020-05-05 President And Fellows Of Havard College Macrolides with modified desosamine sugars and uses thereof
EP3190122A1 (en) * 2016-01-08 2017-07-12 LEK Pharmaceuticals d.d. A novel synthetic pathway towards solithromycin and purification thereof
CN106432383A (zh) * 2016-09-14 2017-02-22 重庆两江药物研发中心有限公司 索利霉素及其中间体的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5671074A (en) * 1979-11-12 1981-06-13 Takeda Chem Ind Ltd 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
FR2669337B1 (fr) * 1990-11-21 1995-03-24 Roussel Uclaf Nouveaux derives descladinosyles de l'erythromycine, leur procede de preparation et leur application comme medicaments.
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP1291352B1 (en) * 1996-09-04 2005-05-25 Abbott Laboratories 6-O-substituted ketolides having antibacterial activity
AU4472897A (en) * 1997-03-10 1998-09-29 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives

Also Published As

Publication number Publication date
SI20640A (sl) 2002-02-28
DE69905447T2 (de) 2003-07-24
CN1240708C (zh) 2006-02-08
WO2000027857A2 (fr) 2000-05-18
IL142996A (en) 2006-12-10
NZ511609A (en) 2003-07-25
JP2000143689A (ja) 2000-05-26
US6455505B2 (en) 2002-09-24
CA2350651A1 (fr) 2000-05-18
EA200100533A1 (ru) 2001-10-22
AR025814A1 (es) 2002-12-18
BR9915236A (pt) 2002-01-08
US20020013281A1 (en) 2002-01-31
AU766138B2 (en) 2003-10-09
DE69905447D1 (de) 2003-03-27
CA2350651C (fr) 2010-07-20
KR20010080970A (ko) 2001-08-25
CN100351238C (zh) 2007-11-28
ATE232879T1 (de) 2003-03-15
US6407257B1 (en) 2002-06-18
JP4698783B2 (ja) 2011-06-08
HRP20010335B1 (en) 2003-08-31
ES2189365T3 (es) 2003-07-01
WO2000027857A3 (fr) 2000-08-17
CZ20011622A3 (cs) 2001-09-12
AU1052600A (en) 2000-05-29
CN1814592A (zh) 2006-08-09
CN1333782A (zh) 2002-01-30
TWI237027B (en) 2005-08-01
EP1016669B1 (fr) 2003-02-19
HUP0104035A2 (hu) 2002-02-28
IL142996A0 (en) 2002-04-21
NO20012272L (no) 2001-07-10
ZA200103801B (en) 2002-05-10
HRP20010335A2 (en) 2002-06-30
EP1016669A1 (fr) 2000-07-05
US20020028781A1 (en) 2002-03-07
PL348098A1 (en) 2002-05-06
TR200101286T2 (tr) 2001-09-21
NO20012272D0 (no) 2001-05-09
PT1016669E (pt) 2003-07-31
HUP0104035A3 (en) 2003-12-29
KR100567695B1 (ko) 2006-04-05
FR2785612A1 (fr) 2000-05-12

Similar Documents

Publication Publication Date Title
DK1016669T3 (da) Nye erythromycinderivater, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler
NO964654L (no) Nye erytromycinderivater, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler
DK0676409T3 (da) Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
DK0885234T3 (da) Nye erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
NO20003496D0 (no) Nye aromatiske amider, fremgangsmÕte for fremstilling av disse, samt deres anvendelse som medisiner
NO20006029L (no) Pyrazolinderivater, deres fremstilling og anvendelse som legemidler
NO20032735L (no) Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene samt deres anvendelse
NO993003L (no) Sulfonamid-derivater, fremgangsmÕte for deres fremstilling og deres anvendelse som medikamenter
NO994671D0 (no) Aryl- eller heteroarylsulfonamid-substituerte hydroksamsyrederivater, fremgangsmaate til fremstillint derav og deres anvendelse som farmasöytika
NO995745D0 (no) Nye derivater av erytromycin, fremgangsmåte for fremstilling av disse, samt deres anvendelse som medikamenter
NO20011503D0 (no) Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, deres fremstilling og anvendelse som anorektiske legemidler
NO20005146L (no) Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
DK1246807T3 (da) Hydantoin-, thiohydantoin-, purimidindion- og thioxopyrimidinonderivater, fremgangsmåder til deres fremstilling og deres anvendelse som lægemidler
DK1015421T3 (da) Nye phenylamidinderivater, fremgangsmåder til deres fremstilling og deres anvendelse som lægemidler
NO20003661D0 (no) Nye pentasakkarider, fremgangsmÕter for deres fremstilling og farmasøytiske preparater inneholdende de samme
DK1118610T3 (da) Benzensulfonamid-derivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne
DK0931088T3 (da) Nye erythromycinforbindelser, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler
NO20035163D0 (no) Nye piperidinkarboksamid-derivater, fremgangsmåte for deres fremstilling ogfarmasöytiske preparater inneholdende de samme
NO20024590L (no) Farmasöytiske preparater inneholdende oligosakkarider, de nye oligosakkarider samt deres fremstilling
NO985790D0 (no) Nye aromatiske derivater substituert med ribose, fremgangsmÕte for fremstilling derav samt deres anvendelse som medikamenter
NO993124D0 (no) Nye erytromycinderivater, fremgangsmÕte for fremstilling av disse samt deres anvendelse som medisiner
NO992859L (no) Nye derivater av erytromycin, fremgangsmÕte for fremstilling av disse og deres anvendelse som medikamenter
DK1036090T3 (da) Echinocandinderivater, fremgangsmåde til deres fremstilling samt deres anvendelse som antifungale midler
DK0863139T3 (da) Nye benzoxazindionderivater, fremgangsmåde til fremstilling deraf samt anvendelse deraf
DK1129208T3 (da) Vancoresmycin, fremgangsmåde til dets fremstilling samt dets anvendelse som farmaceutisk middel